Richard Francis

Richard Francis is global head of Sandoz, the generic drugs division of Novartis. He is a member of the Swiss pharmaceutical company's executive committee. He joined Sandoz after a 13-year career in U.S. biotechnology firm Biogen Idec, where he led the development of several drugs to treat multiple sclerosis. Prior to that, Francis worked for Sanofi in the United Kingdom.